Sumitomo Mitsui Trust Group Inc. Reduces Holdings in Encompass Health Corporation $EHC

Sumitomo Mitsui Trust Group Inc. cut its position in Encompass Health Corporation (NYSE:EHC) by 8.0% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 929,348 shares of the company’s stock after selling 81,260 shares during the quarter. Sumitomo Mitsui Trust Group Inc.’s holdings in Encompass Health were worth $89,896,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. Northwestern Mutual Wealth Management Co. lifted its holdings in Encompass Health by 3,059,159.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company’s stock worth $402,640,000 after buying an additional 3,793,358 shares in the last quarter. AlphaCore Capital LLC acquired a new stake in Encompass Health during the 4th quarter valued at approximately $4,881,000. Tudor Investment Corp ET AL grew its stake in Encompass Health by 155.3% during the 3rd quarter. Tudor Investment Corp ET AL now owns 210,712 shares of the company’s stock valued at $26,765,000 after purchasing an additional 128,191 shares in the last quarter. SG Americas Securities LLC increased its holdings in Encompass Health by 1,070.9% during the 4th quarter. SG Americas Securities LLC now owns 88,054 shares of the company’s stock worth $9,346,000 after purchasing an additional 80,534 shares during the last quarter. Finally, Cinctive Capital Management LP raised its position in shares of Encompass Health by 48.6% in the 3rd quarter. Cinctive Capital Management LP now owns 66,898 shares of the company’s stock valued at $8,497,000 after purchasing an additional 21,887 shares in the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Encompass Health Stock Performance

EHC stock traded down $1.32 during trading on Friday, hitting $109.70. 1,069,745 shares of the company’s stock traded hands, compared to its average volume of 1,137,027. The stock has a market capitalization of $10.88 billion, a price-to-earnings ratio of 18.31, a price-to-earnings-growth ratio of 2.42 and a beta of 0.74. Encompass Health Corporation has a 52 week low of $92.77 and a 52 week high of $127.99. The stock has a fifty day moving average price of $103.88 and a two-hundred day moving average price of $103.50. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC) last issued its earnings results on Thursday, April 30th. The company reported $1.60 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.51 by $0.09. The firm had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.57 billion. Encompass Health had a net margin of 10.04% and a return on equity of 18.28%. Encompass Health’s revenue was up 9.0% on a year-over-year basis. During the same quarter last year, the company posted $1.37 earnings per share. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. As a group, equities analysts anticipate that Encompass Health Corporation will post 5.97 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be paid a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Wednesday, July 1st. Encompass Health’s dividend payout ratio is presently 12.69%.

Insiders Place Their Bets

In other Encompass Health news, EVP Patrick William Tuer sold 682 shares of the firm’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $104.56, for a total value of $71,309.92. Following the sale, the executive vice president directly owned 24,755 shares in the company, valued at approximately $2,588,382.80. This trade represents a 2.68% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 1.80% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several research firms have recently commented on EHC. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Leerink Partners set a $152.00 price target on shares of Encompass Health in a report on Friday, May 22nd. Weiss Ratings downgraded shares of Encompass Health from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, June 26th. TD Cowen began coverage on shares of Encompass Health in a report on Thursday, May 28th. They set a “buy” rating and a $125.00 price objective for the company. Finally, Barclays cut their target price on shares of Encompass Health from $153.00 to $140.00 and set an “overweight” rating on the stock in a research note on Tuesday, May 5th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $143.86.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post?acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end?of?life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.